Back to today’s briefing

Story perspectives

Study: Indian Generic Drugs Risk 54% More Side Effects

2/25/2025

31 6

Summary

Story summary

A revealing study from Ohio State University uncovers a startling truth: generic drugs produced in India are linked to 54% more severe side effects than their U.S. counterparts. This alarming disparity stems from varying manufacturing standards and regulatory practices. To safeguard public health, researchers advocate for surprise inspections and clearer labeling of drug origins.

1 of 1

Story summary

A revealing study from Ohio State University uncovers a startling truth: generic drugs produced in India are linked to 54% more severe side effects than their U.S. counterparts. This alarming disparity stems from varying manufacturing standards and regulatory practices. To safeguard public health, researchers advocate for surprise inspections and clearer labeling of drug origins.